Fascioliasis and eosinophilia in the highlands of Cuzco, Peru and their association with water and socioeconomic factors

American Journal of Tropical Medicine and Hygiene

Volumn 91, Issue 5, 2014, Pages 989-993

  Cabada, Miguel M ^a,b   Goodrich, Mary R ^c   Graham, Brittany ^c   Villanueva Meyer, Pablo G ^c   Lopez, Martha ^a   Arque, Eulogia ^a   White, A Clinton ^c  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; ALBENDAZOLE;

ARTICLE; ASCARIASIS; ASCARIS; CHILD; EATING; EOSINOPHILIA; FASCIOLA; FASCIOLIASIS; FEMALE; GIARDIA; GIARDIASIS; HOOKWORM; HOOKWORM INFECTION; HOUSEHOLD; HUMAN; HYMENOLEPIASIS; HYMENOLEPIS; MAJOR CLINICAL STUDY; MALE; PERU; SIBLING; SOCIOECONOMICS; STRONGYLOIDES; STRONGYLOIDIASIS; TRICHURIASIS; TRICHURIS; WATER CONTAMINATION; WATER SUPPLY; WATER TREATMENT; ANALYSIS; ANIMAL; CROSS-SECTIONAL STUDY; FASCIOLA HEPATICA; FECES; FOOD CONTAMINATION; FOOD CONTROL; ISOLATION AND PURIFICATION; PARASITE IDENTIFICATION; PARASITOLOGY; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR;

ANCYLOSTOMATOIDEA; ASCARIS; FASCIOLA; GIARDIA; STRONGYLOIDES; TRICHURIS;

ALBENDAZOLE; ANIMALS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRINKING WATER; EOSINOPHILIA; FASCIOLA HEPATICA; FASCIOLIASIS; FECES; FEMALE; FOOD CONTAMINATION; FOOD PARASITOLOGY; HUMANS; MALE; PARASITE EGG COUNT; PERU; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84910615108     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0169     Document Type: Article

References (26)

1. World Health Organization, 2007. Fascioliasis: Infection with the "Neglected" Neglected Worms. Available at: http://www.who.int/neglected-diseases/integrated-media/integrated-media-fascioliasis/en. Accessed March 18, 2014.
2. Mas-Coma S, Valero MA, Bargues MD, 2009. Chapter 2: Fasciola, lymnaeids, and human fascioliasis, with a global overview of disease transmission, epidemiology, evolutionary genetics, molecular epidemiology, and control. Adv Parasitol 69: 41-146.
3. Cabada MM, White AC Jr, 2012. New developments in the epidemiology, diagnosis, and treatment of fascioliasis. Curr Opin Infect Dis 25: 518-522.
4. Marcos LA, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, Miranda E, TantaleánM, Gotuzzo E, 2005. Altas tasas de prevalencia de fasciolosis humana en el Peru: una enfermedad emergente. Rev Peru Enferm Infecc Trop 3: 8-13.
5. Parkinson M, O'Neill SM, Dalton JP, 2006. Endemic human fasciolosis in the Bolivian Altiplano. Epidemiol Infect 26: 1-6.
6. Marcos LA, Maco V, Terashima A, Samalvides F, Gotuzzo E, 2002. Caracteristicas clínicas de la infección crónica por Fasciola hepatica en niños. Rev Gastroenterol Peru 22: 228-233.
7. Marcos LA, Maco V, Castillo M, Terashima A, Serpa R, Gotuzzo E, 2005. Reporte de casos de fasciolasis en el Instituto Especializado de Salud del Nino, Lima-Peru (1988-2003) Rev Gastroenterol Peru 25: 198-205.
8. El-Shazly AM, El-Nahas HA, Abdel-Mageed AA, El Beshbishi SN, Azab MS, Abou El Hasan M, Arafa WA, Morsy TA, 2005. Human fascioliasis and anaemia in Dakahlia governorate, Egypt. J Egypt Soc Parasitol 35: 421-432.
9. Lopez M, White AC, Cabada MM, 2012. Burden of Fasciola hepatica infection among children from Paucartambo in Cuzco, Peru. Am J Trop Med Hyg 86: 481-485.
10. Karahocagil MK, Akdeniz H, Sunnetcioglu M, Cicek M, Mete R, Akman N, Ceylan E, Karsen H, Yapici K, 2011. A familial outbreak of fascioliasis in eastern Anatolia: a report with review of literature. Acta Trop 118: 177-183.
11. Marcos LA, Terashima A, Leguia G, Canales M, Espinoza JR, Gotuzzo E, 2007. La infeccion por Fasciola hepatica en el Peru: una enfermedad emergente. RevGastroenterol Peru 27: 389-396.
12. Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207-216.
13. Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E, 2006. Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 100: 158-166.
14. Zumaquero-Rios JL, Sarracent-Perez J, Rojas-Garcia R, Rojas-Rivero L, Martinez-Tovilla Y, Valero MA, Mas-Coma S, 2013. Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide. PLoS Negl Trop Dis 7: e2553.
15. Maco-Flores V, Marcos-Raymundo L, Terashima-Iwashita A, Samalbvides-Cuba F, Miranda-Sanchez E, Espinoza-Babilon J, Gotuzzo-Herencia J, 2002. Fas-2 ELISA and the Rapid Sedimentation Technique Modified by Lumbreras for Fasciola Hepatica Infection Diagnosis. Available at: http://www.scielo .org.pe/pdf/rmh/v13n2/v13n2ao3.pdf. Accessed March 18, 2014.
16. Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T, 2006. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 64 (Suppl 2): S34-S43.
17. World Health Organization, 2013. Fascioliasis Diagnosis, Treatment and Control Strategy. Available at: http://www.who.int/foodborne-trematode-infections/fascioliasis/fascioliasis-diagnosis/en/index.html. Accessed March 11, 2014.
18. Villegas F, Angles R, Barrientos R, Barrios G, Valero MA, Hamed K, Grueninger H, Ault SK, Montresor A, Engels D, Mas-Coma S, Gabrielli AF, 2012. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano. PLoS Negl Trop Dis 76: e1720.
19. Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P, 2012. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 11: CD000371.
20. Awasthi S, Peto R, Read S, Richards SM, Pande V, Bundy D; DEVTA (Deworming and Enhanced Vitamin A) Team, 2013. Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a clusterrandomized trial. Lancet 381: 1478-1486.
21. Esteban JG, Gonzalez C, Bargues MD, Angles R, Sánchez C, Náquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7: 339-348.
22. Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, Mas-Coma S, 1997. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the northern Bolivian Altiplano. Acta Trop 66: 1-14.
23. Heukelbach J, Poggensee G, Winter B, Wilcke T, Kerr-Pontes LR, Feldmeier H, 2006. Leukocytosis and blood eosinophilia in a polyparasitised population in north-eastern Brazil. Trans R Soc Trop Med Hyg 100: 32-40.
24. Fica A, Dabanch J, Farias C, Castro M, Jercic MI, Weitzel T, 2012. Acute fascioliasis-clinical and epidemiological features of four patients in Chile. Clin Microbiol Infect 18: 91-96.
25. Kaya M, Beştaş R, Çetin S, 2011. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 17: 4899-4904.
26. Esteban JG, Flores A, Angles R, Mas-Coma S, 1999. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop Med Hyg 93: 151-156.